Ameriprise’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,639
| Closed | -$883K | – | 4045 |
|
|
2024
Q2 | $883K | Buy |
32,639
+21,107
| +183% | +$439K | ﹤0.01% | 3198 |
|
|
2024
Q1 | $211K | Buy |
+11,532
| New | +$183K | ﹤0.01% | 3674 |
|
|
2023
Q2 | – | Sell |
-80,824
| Closed | -$3.16M | – | 4024 |
|
|
2023
Q1 | $3.16M | Buy |
80,824
+810
| +1% | +$39.6K | ﹤0.01% | 2611 |
|
|
2022
Q4 | $4.23M | Buy |
80,014
+52,874
| +195% | +$2.58M | ﹤0.01% | 2410 |
|
|
2022
Q3 | $1.22M | Sell |
27,140
-4,537
| -14% | -$195K | ﹤0.01% | 3022 |
|
|
2022
Q2 | $1.15M | Buy |
31,677
+4,685
| +17% | +$170K | ﹤0.01% | 3056 |
|
|
2022
Q1 | $1.11M | Sell |
26,992
-490,835
| -95% | -$17.3M | ﹤0.01% | 3165 |
|
|
2021
Q4 | $22.1M | Sell |
517,827
-87,672
| -14% | -$4.39M | 0.01% | 1324 |
|
|
2021
Q3 | $33.3M | Buy |
605,499
+861
| +0.1% | +$45.1K | 0.01% | 948 |
|
|
2021
Q2 | $28.9M | Sell |
604,638
-11,038
| -2% | -$562K | 0.01% | 1089 |
|
|
2021
Q1 | $31.2M | Buy |
615,676
+262,376
| +74% | +$14.6M | 0.01% | 1020 |
|
|
2020
Q4 | $22.2M | Buy |
353,300
+91,074
| +35% | +$5.65M | 0.01% | 1163 |
|
|
2020
Q3 | $17.6M | Sell |
262,226
-83,308
| -24% | -$4.55M | 0.01% | 1154 |
|
|
2020
Q2 | $14.4M | Buy |
345,534
+323,544
| +1,471% | +$12.4M | 0.01% | 1274 |
|
|
2020
Q1 | $692K | Buy |
21,990
+5,180
| +31% | +$207K | ﹤0.01% | 2983 |
|
|
2019
Q4 | $679K | Buy |
16,810
+1,520
| +10% | +$53.2K | ﹤0.01% | 3231 |
|
|
2019
Q3 | $497K | Buy |
15,290
+90
| +0.6% | +$3.59K | ﹤0.01% | 3304 |
|
|
2019
Q2 | $737K | Buy |
+15,200
| New | +$646K | ﹤0.01% | 3184 |
|
Other funds holding SILK
Ameriprise's SILK Position: Q3 2024 in Review
Ameriprise sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 32,639 shares — an estimated $883K sold.
Ameriprise first reported a position in SILK in Q2 2019 and held it in 18 quarters. The position peaked at $33.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Ameriprise reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Ameriprise sold 32,639 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $883K.
- Ameriprise first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- Ameriprise's Silk Road Medical, Inc. Common Stock position peaked at $33.3M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.